Express News | SELLAS Life Sciences Gr Q4 EPS $(0.25) Misses $(0.21) Estimate
Moomoo 24/7Mar 28 23:35 ET
SELLAS Life Sciences GAAP EPS of -$1.34 Misses by $0.24
Seeking AlphaMar 28 16:57 ET
Express News | Sellas Life Sciences Group Files For Mixed Shelf Offering Of Up To $200M
Moomoo 24/7Mar 28 16:50 ET
SELLAS Life Sciences 2023 R&D Expenses $24M >SLS
SELLAS Life Sciences 2023 R&D Expenses $24M >SLS
Dow JonesMar 28 16:11 ET
Press Release: SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update -- Announced Phase 2a study of SLS009 in r/r AML Showing 50% Response Rate in the Selected Optimal
Dow JonesMar 28 16:05 ET
Buy Rating for SELLAS Life Sciences Amid Positive AML Study Results and Strengthened Financials
TipRanksMar 27 14:25 ET
SELLAS Announces Topline Data From Phase 2a Study of SLS009 In Relapsed/Refractory Acute Myeloid Leukemia And Provides Steering Committee Update on Phase 3 REGAL Study
Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April -Phase 2a study of SLS009 in r/r AML: 50% Response Rate i
BenzingaMar 26 07:37 ET
Press Release: SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules NEW YORK, March 19, 2024 (GLOBE NEWSWIR
Dow JonesMar 19 16:05 ET
SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Yahoo FinanceMar 19 16:05 ET
SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 Am ET
Yahoo FinanceMar 19 08:47 ET
Dow Falls Over 200 Points; Adobe Shares Plunge
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded down 0.55% to 38,692.43 while the NASDAQ fell 0.90% to 15,982.65. The S&P
BenzingaMar 15 14:40 ET
Top Midday Decliners
C3is (CISS) said Friday it priced a firm commitment underwritten public offering of 120 million units, with gross proceeds of about $6 million. Net proceeds will be used for capital expenditures, incl
MT NewswiresMar 15 14:01 ET
Sector Update: Health Care Stocks Softer Friday Afternoon
Health care stocks fell Friday afternoon with the NYSE Health Care Index falling 0.8% and the Health Care Select Sector SPDR Fund (XLV down 0.5%. The iShares Biotechnology ETF (IBB) rose 0.1%. In corp
MT NewswiresMar 15 13:52 ET
VERI, STI and VERB Among Mid-day Movers
Seeking AlphaMar 15 12:52 ET
Crude Oil Edges Lower; US Consumer Sentiment Falls In March
U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Friday. The Dow traded down 0.37% to 38,761.74 while the NASDAQ fell 0.95% to 15,974.83. The S&P 50
BenzingaMar 15 12:05 ET
Express News | SELLAS Life Sciences Group Shares Are Trading Lower After the Company Announced a $20 Million Registered Direct Offering and Concurrent Private Placement of 13,029,316 Shares Each for a Combined Purchase Price of $1.535 per Share
Moomoo 24/7Mar 15 11:40 ET
Sellas Life Sciences Launches $20 Million Direct Offering, Private Placement -- Shares Fall
Sellas Life Sciences (SLS) said Friday it has signed agreements with two investors for the purchase and sale of about 13 million shares in a direct offering and warrants to buy up to the same number o
MT NewswiresMar 15 11:07 ET
Geron, Graphite Bio, Immuneering Among Healthcare Movers
Seeking AlphaMar 15 10:00 ET
Nasdaq Down Over 100 Points; Hibbett Reports Downbeat Sales
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.28% to 38,797.24 while the NASDAQ fe
BenzingaMar 15 09:58 ET
Sellas Life Sciences Shares Drop 31% After Direct Offering Prices
By Chris Wack Sellas Life Sciences Group shares were down 31% at $1.07 after the company entered into definitive agreements with two existing institutional investors for the purchase and sale of 13 m
WSJMar 15 09:52 ET
No Data
No Data